204
Participants
Start Date
August 31, 2016
Primary Completion Date
November 30, 2018
Study Completion Date
January 31, 2024
ReActiv8 Implantable Stimulation System (Patient Appropriate Stimulation)
ReActiv8 implanted and configured to deliver stimulation at a patient-appropriate level, and participants instructed to deliver stimulation in two 30-minute sessions per day.
ReActiv8 Implantable Stimulation System (Low Stimulation)
ReActiv8 implanted and configured to deliver low stimulation, and participants instructed to deliver stimulation in two 30-minute sessions per day.
University of California, San Diego, La Jolla
The Spine Institute, Santa Monica
University of Colorado Hospital, Aurora
Indiana Spine Group, Carmel
OrthoIndy, Indianapolis
University of Kansas Medical Center, Kansas City
The Brigham and Women's Hospital, Boston
Beaumont Health, Royal Oak
Duke University Medical Center, Durham
Center for Clinical Research, Winston-Salem
Louis Stokes VA Medical Center, Cleveland
University Hospitals Cleveland Medical Center, Cleveland
Rhode Island Hospital, Providence
Upstate Clinical Trials, Spartanburg
Northwest Orthopaedic Specialists, Spokane
Center for Pain Relief, Charleston
Genesis Research Services, Broadmeadow
Sunshine Coast Clinical Research, Noosa
Pain Medicine of South Australia, Welland
Monash Clinical Research, Clayton
AZ Nikolaas, Sint-Niklaas
Sint Augustinus, Wilrijk
Erasmus MC University Medical Center, Rotterdam
Seacroft Hospital, Leeds
St. Bartholomew's Hospital, London
The James Cook University Hospital, Middlesbrough
Lead Sponsor
Mainstay Medical
INDUSTRY